SHAPING YOUR PRACTICE. SHAPING YOUR PATIENTS.

SHAPING THE FUTURE.

REVOLUTIONIZE body contouring procedures with the AYON Body Contouring System™

AYON™ unites multiple liposuction procedure steps into a single, intuitively designed system.

Designed by world-leading surgeons with surgeons’ needs in mind, the AYON System offers next-generation body contouring technology that enhances precision, empowers operational consistency, and delivers complete control across every phase of body contouring.

WHY PATIENTS LOVE AYON

Tumescent infiltration with integrated pumps and flow-controlled cannulas.

Steady suction performance powered by PEAK mode.

Ultrasound-assisted liposuction for fragmentation and emulsification of fat.

Streamlines the collection and handling of material
for repurposing in other areas.

INTENDED PURPOSE

The AYON BODY CONTOURING SYSTEM™ is intended for the fragmentation, emulsification, and aspiration of subcutaneous fatty tissue.

  • The AYON Body Contouring Ultrasound Subsystem is used for the fragmentation and emulsification of subcutaneous fatty tissues.
  • The AYON Body Contouring Infiltration and Aspiration Subsystem(s) are used for the infiltration and suction / aspiration of fluids and tissue during surgical procedures. Infiltration and Suction is designed to operate as a stand-alone function.

The following is a description of the mechanism of action of the AYON Body Contouring System subsystems.

  • The infiltration system delivers the tumescent through an infiltration tubing connected to a cannula. This system utilizes rotary pump to push the fluid through the infiltration tubing.
  • Ultrasound assisted liposuction uses ultrasonic waves to emulsify fat in the patient’s target area, later to be removed or aspirated by means of aspiration cannula.
  • Suction assisted liposuction uses negative air pressure (vacuum) while connected to an aspiration cannula to remove fat from patient’s target area.

As with all energy devices there are inherent risks associated with its use. Risks associated with the use of the AYON BODY CONTOURING SYSTEM™ may include: hyper- or hypovolaemia, cardiac arrhythmias, venous thromboembolism, fat embolism, visceral perforation, burn, seroma, vasculitis, bleeding, bruising or hematoma fibrosis, infection, skin erythema or panniculitis, hyper or hypopigmentation, hyperesthesia, hyper- or hypotension, temporary or permanent nerve damage, bradycardia, fluid accumulation, contour irregularities and unacceptable cosmetic result. Expected clinical side effects may include discomfort/pain, edema, erythema, ecchymosis, hypoesthesia, touch sensitivity, itching, temporary weight gain, temporary numbness/tingling, subcutaneous nodules or lumps (transient migratory firmness), temporary and/or transient crepitus.

The AYON Body Contouring System™ is not currently approved for use in the EU. AYON™ is cleared by the US FDA, indicated for the use of fragmentation, emulsification, and aspiration of subcutaneous fatty tissue for the purpose of aesthetic body contouring in the United States.